Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing tags : Pharm-country save search
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: 1.17%
H: 0.29%
C: -5.41%
htx-100 pharmaceuticals
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: 895.97%
H: 14.34%
C: 11.7%
business year update pharmaceuticals financial results
NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: -31.5%
H: 5.02%
C: 0.38%
million offering
NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: 6.89%
H: 0.81%
C: -9.08%
ceo conference hope pharmaceuticals
NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: -0.45%
H: 5.36%
C: -4.01%
ceo conference hope pharmaceuticals
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
HYPR | $0.806 -1.59% -1.61% 69K
|
Manufacturing
|
| O: 3.74%
H: 0.0%
C: -2.7%
swoop conference stroke update international system study
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
Published: 2023-12-19 (Crawled : 14:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: -4.99%
H: 10.0%
C: -2.48%
ketamine depression treatment pharmaceuticals agreement
Terumo Medical Corporation's New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: 1.44%
H: 1.37%
C: 0.0%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: 3.39%
H: 0.0%
C: -3.23%
solution system medical
Scientific Industries to Report Third Quarter 2023 Financial Results on November 14, 2023
Published: 2023-11-13 (Crawled : 21:00) - biospace.com/
SCND | $1.4 0.5% 11K
|
Manufacturing
|
| O: -0.77%
H: 0.0%
C: 0.0%
report financial results
NRx Pharmaceuticals to Present at 8th Annual Dawson James Conference
Published: 2023-10-05 (Crawled : 19:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: 0.0%
H: 2.5%
C: -1.79%
conference pharmaceuticals
Lokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific
Published: 2023-10-03 (Crawled : 12:30) - biospace.com/
ROIV | $10.89 -0.46% -0.46% 2.8M
|
Manufacturing
|
| O: -1.0%
H: 1.15%
C: 0.1%
trial
NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug (IND) Application for NRX-101 to Treat Chronic Pain
Published: 2023-10-02 (Crawled : 19:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: 4.81%
H: 5.72%
C: 5.36%
nrx-101 fda drug permission treat pharmaceuticals application
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Published: 2023-09-20 (Crawled : 16:00) - biospace.com/
ACHL | $0.7764 -0.6% -0.61% 120K
|
Manufacturing
|
| O: 0.9%
H: 5.52%
C: 2.96%
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: 0.58%
H: 1.04%
C: 0.84%
GNPX | $2.31 6.77% 20K
|
Health Technology
|
| O: -0.55%
H: 3.29%
C: -0.44%
ALXO M | $16.24 4.77% 4.56% 440K
|
Commercial Services
|
| O: -0.2%
H: 1.21%
C: -2.63%
drug biotech designation
NRX Pharmaceuticals Announces Data Sharing Agreement Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Bipolar Depression
Published: 2023-09-15 (Crawled : 19:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: 2.44%
H: 16.04%
C: 7.55%
ketamine depression treatment pharmaceuticals agreement
Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-09-11 (Crawled : 12:30) - biospace.com/
NTRB | $3.56 -8.76% 3.4K
|
Manufacturing
|
| O: 5.34%
H: 6.81%
C: 3.26%
business update financial results
NRx Pharmaceuticals Announces Potent Antibacterial Activity of NRX-101 Against Common, Antibiotic Resistant Urinary Pathogens
Published: 2023-09-06 (Crawled : 18:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: -1.71%
H: 12.22%
C: -1.15%
nrx-101 antibacterial pharmaceuticals pathogens
NRx Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for NRX-101 in the Treatment of Chronic Pain
Published: 2023-08-30 (Crawled : 12:00) - biospace.com/
NRXP 5 d | $3.11 1.97% 1.93% 96K
|
Manufacturing
|
| O: -0.78%
H: 0.0%
C: -3.94%
nrx-101 drug treatment pharmaceuticals application submission
Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
Published: 2023-08-14 (Crawled : 17:00) - biospace.com/
QRON | $0.213 0% 3.2K
|
Manufacturing
| Email alert
Add to watchlist
patent disease application
Eli Lilly Selects ABEC for World’s Largest Single-Use Biopharmaceutical Manufacturing Facility
Published: 2023-07-10 (Crawled : 12:00) - biospace.com/
PPRUF | News | $340.0 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 2.42%
H: 0.0%
C: -1.8%
PPRUY | News | $33.79 -0.11% 360K
|
Manufacturing
|
| O: 0.31%
H: 0.99%
C: 0.99%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.19%
H: 0.38%
C: 0.04%
Manhattan Scientifics Celebrates Imagion Biosystems' Milestones in Early Cancer Detection Technology
Published: 2023-05-31 (Crawled : 16:00) - biospace.com/
MHTX | $0.0017 -36.84% 290K
|
Manufacturing
| Email alert
Add to watchlist
cancer technology
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.